Compliance Certificate under regulation 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended on March 31, 2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bharat Parenterals Ltd has submitted a routine compliance certificate for Q4 FY2025-26 (ending March 31, 2026) confirming proper handling of share dematerialization. The filing from RTA Adroit Corporate Services confirms that securities received from depository participants were properly processed and confirmed to depositories. Physical share certificates submitted for dematerialization have been mutilated and cancelled, with depository names substituted as registered owners in the register of members within the mandated 15-day period. This is a standard quarterly regulatory requirement under SEBI (Depositories and Participants) Regulations, 2018. The Company Secretary and Compliance Officer, Sharmin Soni, has certified the filing.
This is a routine regulatory compliance filing with no direct impact on the company's financials or operations. No material information for investors — the certificate confirms standard dematerialization procedures were followed correctly during the quarter.